How to Cite
Abstract
The study involved 99 patients with arterial hypertension II stage, which were divided into 4 groups. 1st group (23 patients) with isolated hypertension II stage, 2nd group (27 patients) with obesity, 3rd (24 patients) with diabetes mellitus and in the 4th (25 patients) with diabetes and obesity. The study also included 20 people with no signs of arterial hypertension, diabetes and obesity (heart rate within normal range) as the control group. It was found that only comorbidity of hypertension with obesity and diabetes, but not in single combination, may increase left ventricular dimensions, affecting the reduction of inotropic function of the heart. Majority of hypertensive patients with comorbid pathology of diastolic dysfunction was presented by slow relaxation type of violations.References
Неинвазивные методы исследования магистральных сосудов / В.А. Милягин, И.В. Милягина, Н.Ю. Абраменкова и др. // Смоленск, 2012. – 224 с.
The risk of heart failure associated with the use of noninsulin blood glucose-lowering drugs: systematic review and meta-analysis of published observational studies / C. Varas-Lorenzo, A.V. Margulis, M. Pladevall et al. // BMC Cardiovasc. Disord. – 2014 . – Vol. 14 (1), Sep 26. – Р. 129.
Resistin, adiponectin, and risk of heart failure. The Framingham Offspring study / D.S. Frankel, R.S. Vasan, R. D’Agostino et al. // J. Am. Coll. Cardiol. – 2009. – Vol. 53. – P. 754–762.
Obesity and the risk of new-onset atrial fibrillation / T.J. Wang, H. Parise,
D. Levy et al. // J. Am. Med. Assoc. – 2004. – Vol. 292. – P. 2471–2477.
Roman M.J. Relations of central and brachial blood pressure to left ventricular hypertrophy and geometry: the Strong Heart Study / M.J. Roman, P.M. Okin, J.R. Kiser // J. Hypertens. – 2010. – Vol. 28 (2). – P. 384–388.
Left ventricular hypertrophy in severe obesity: interactions among blood pressure, nocturnal hypoxemia, body mass / E. Avelar, T. Cloward, J.M. Walker et al. // Hypertension. – 2007. – Vol. 49. – P. 34–39.
Iacobellis G. Epicardial adipose tissue and insulin resistance in obese subjects / G. Iacobellis, F. Leonetti // J. Clin. Endocrinol. Metab. – 2005. – Vol. 90. – P. 6300–6302.
Диастолическая дисфункция левого желудочка у больных гипертонической болезнью: возможности коррекции с помощью валсартана / Е.П. Свищенко, Е.А. Матова, Л.А. Мищенко и др. // Артериальная гипертензия. – 2012. – № 2 (22). – С. 39–46.
Капелько В.И. Диастолическая дисфункция / В.И. Капелько // Кардиология. – 2011. – № 1. – С. 79–90.
Aljaroudi W. Inpact of progression of diastolic dysfunction on mortality in patients with normal ejection fraction / W. Aljaroudi, M.C. Alraies, C. Halley // Circulation. – 2012. – Vol. 14, № 126 (6). – P. 782–788.
Прокофьева Е.Б. Жесткость артериальной стенки и показатели центральной гемодинамики на фоне длительной комбинированной антигипертензивной терапии / Е.Б. Прокофьева, М.Г. Глезер // Кардиология. – 2015. – № 4. – С. 19–24.
Терегулов Ю.Э. Изучение и сравнительный анализ показателей центральной гемодинамики и артериального давления у пациентов гипертонической болезнью и гипотиреозом с артериальной гипертонией / Ю.Э. Терегулов, Е.Т. Терегулова // Практическая медицина. – 2013. – Т. 1. – № 1–2 (69). – С. 111–116.
New echocardiographic techniques in the evaluation of left ventricular function in obesity / V. Di Bello, I. Fabiani, L. Conte et al. // Obesity. – 2013. – № 21 (5). – Р. 881–892.
Use of body weight and insulin resistance to select obese patients for echocardiographic assessment of subclinical left ventricular dysfunction / W. Kosmala, C. Wong, J. Kuliczkowska et al. // Am. J. Cardiol. – 2008. – Vol. 1, № 101 (9). – Р. 1334–1340.